Market Currents
More good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%,...
-
Wednesday, December 14, 2011, 8:47 AM ETMore good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%, continuing the medical device company's streak of double-digit sales growth. Sales of its Peri-Strips for gastric bypass surgery, the biggest contributor to its top line, climbed 28%. Yesterday, SYNO agreed to be acquired by Baxter (BAX) for $28/share.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: